US20070204507A1 - Functional substrates for growth of culinary and medicinal mushrooms - Google Patents

Functional substrates for growth of culinary and medicinal mushrooms Download PDF

Info

Publication number
US20070204507A1
US20070204507A1 US11/653,773 US65377307A US2007204507A1 US 20070204507 A1 US20070204507 A1 US 20070204507A1 US 65377307 A US65377307 A US 65377307A US 2007204507 A1 US2007204507 A1 US 2007204507A1
Authority
US
United States
Prior art keywords
mushrooms
substrate
anthocyanins
mushroom
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/653,773
Inventor
Andrew Miller
Donald Kinoshita
Roger Drummer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Functional Fungi LLC
Original Assignee
Functional Fungi LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Functional Fungi LLC filed Critical Functional Fungi LLC
Priority to US11/653,773 priority Critical patent/US20070204507A1/en
Publication of US20070204507A1 publication Critical patent/US20070204507A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G18/00—Cultivation of mushrooms
    • A01G18/20—Culture media, e.g. compost

Definitions

  • This invention relates to substrates for use in growing mushrooms and methods of increasing the growth rate of mushrooms.
  • functional substrates having desirable compounds can be used to grow mushrooms, to increase the levels of these compounds in mushrooms and to improve the growth rate of the mushrooms.
  • functional substrates increase the potency of naturally occurring compounds already present in the mushrooms.
  • a suitably prepared substrate such as corn, rice, millet or rye is impregnated with mushroom spores or previously collected mushroom mycelia.
  • the spores or mycelia are injected into the substrate, which has been prepared by soaking the grain in water and sterilizing it.
  • Mycelia are the filamentous hyphae of a mushroom that collect water and nutrients to enable mushrooms to grow.
  • the grains are incubated to promote full colonization of the mycelia, at which point the mycelia-laced grains are known as “spawn”. Spawning is usually done in a plurality of individual spawn bags.
  • the substrate provides the nutrients necessary for mycelium growth.
  • the mycelium-impregnated substrate is then allowed to develop under carefully controlled conditions of temperature and moisture, until the hyphae of the mycelium have permeated the substrate.
  • This process usually takes anywhere from three to four weeks for the mycelium to fully colonize the spawn bag.
  • the spawn bag is allowed to continue to grow until the mycelium enriched product can be harvested between four to eight weeks from the beginning of the process.
  • mushroom growers purchase spawn or grow it themselves from agar plates, as will be known to one skilled in the art.
  • the spawn bag is the final product, which is then sold or the contents processed into dry powdered product.
  • the maitake mushroom ( Grifola frondosa ) contains grifolan, an important beta-glucan polysaccharide and has been shown to activate macrophages, an important component of the immune system. Laboratory studies have shown that maitake extract can block the growth of cancer tumors and boost the immune function of mice with cancer.
  • shiitake mushrooms possess beneficial properties.
  • a specific amino acid in shiitake helps speed up the processing of cholesterol in the liver.
  • Shiitake also appears to be a daunting cancer fighter.
  • a polysaccharide compound called lentinan has been isolated from shiitake, and in laboratory trials, lentinan appears to stimulate immune-system cells to clear the body of tumor cells. Shiitake appears to be effective against some of the more serious viruses, such as HIV and hepatitis B.
  • Reishi mushrooms have been used in China and Japan for years as a medicine for liver disorders, hypertension, and arthritis, and researchers have found that reishi has anti-allergic, anti-inflammatory, anti-viral, anti-bacterial, and antioxidant properties. In vitro experiments also indicate that reishi may help fight cancer tumors.
  • U.S. Pat. No. 6,747,065 describes methods of producing mushroom mycelia rich in trace minerals by culturing the mycelia in a broth to which supplements have been added.
  • the present invention accomplishes the above by providing in a general aspect a method of increasing the amount of one or more functional compounds in mushrooms by growing the mushrooms on a substrate that is high in the functional compound or compounds of interest.
  • the term “functional compound”, as used herein, means a compound known to one skilled in the art to have certain medicinal or other beneficial properties, such as antioxidant, anti-tumorigenic, antidiabetic, antiviral, and the like. It has been found that growing mushrooms on substrates that have high levels of the compounds of interest permits uptake of the compounds by the mushrooms during the growth cycle, and these levels are maintained during further processing of the mushrooms. Thus, in one aspect, the present invention provides a method of increasing the amount of anthocyanins in medicinal mushroom biomass and mushroom mycelia.
  • the method comprises providing a substrate having one or more anthocyanins therein and growing mushrooms on the substrate.
  • the present invention provides methods of increasing certain other compounds in medicinal mushroom biomass and mushroom mycelia such as selenium or beta glucans, by providing a substrate high in these compounds and growing the mushrooms on the substrate.
  • the present invention provides a method of decreasing the growing time of mushrooms, by providing a substrate rich in anthocyanins.
  • the mushrooms are grown on the anthocyanin-rich substrate, and the time to fruiting is decreased as compared to growing time on substrates not having anthocyanins.
  • the present invention provides a method of increasing the potency of naturally-occurring compounds found in medicinal mushroom biomass.
  • the method comprises providing a substrate high in anthocyanins, and growing the mushrooms on the substrate.
  • the present invention provides a method of increasing the amount of anthocyanins in dried mushroom biomass, comprising providing dried mushroom biomass, and subjecting the dried mushroom biomass to heat treatment.
  • FIG. 1 is a flow chart illustrating the culturing of mushrooms according to a method of the present invention.
  • the present invention provides a method of increasing the amount of one or more functional compounds in medicinal mushroom biomass and mushroom mycelia by growing mushrooms on a substrate that is high in the functional compound or compounds of interest.
  • functional compounds include compounds known to have antioxidant properties including, but not limited to, anthocyanins; compounds known to have antitumor properties including, but not limited to, beta glucans; selenium, ganoderic acid; triterpenes; and cordycepin.
  • muscle biomass refers to mushroom mycelia, fruiting bodies, spawn, or other life cycle stage of a mushroom, alone or in combination with each other or in combination with the substrate on which the mushroom is grown, including the functional substrates described herein.
  • Medical mushroom refers to the varieties of mushrooms grown for their desired medicinal properties or compounds, as is known in the art.
  • the present invention provides a method of increasing the amount of anthocyanins in medicinal mushroom biomass and mushroom mycelia comprising providing a substrate having one or more anthocyanins therein; and growing mushrooms on the substrate.
  • Anthocyanins are well known in the art, and are naturally occurring compounds that are responsible for the red, purple, and blue colors of many fruits, vegetables, cereal grains, and flowers.
  • the colors of berry fruits such as blueberries, bilberries, strawberries, raspberries, boysenberries, marionberries, cranberries, are due to many different anthocyanins.
  • Over 300 structurally distinct anthocyanins have been identified in nature. Because anthocyanins are naturally occurring, they have attracted much interest for use as colorants for foods and beverages. Recently, the interest in anthocyanin pigments has intensified because of their possible health benefits as dietary antioxidants.
  • anthocyanin pigments of bilberries have long been used for improving visual acuity and treating circulatory disorders.
  • anthocyanins and flavonoids have anti-inflammatory properties.
  • orally administered anthocyanins are beneficial for treating diabetes and ulcers and may have antiviral and antimicrobial activities.
  • the chemical basis for these desirable properties of flavonoids is believed to be related to their antioxidant capacity.
  • the antioxidant characteristics associated with berries and other fruits and vegetables have been attributed to their anthocyanin content.
  • Proanthocyanins are another class of flavonoid compounds that are found in fruits and vegetables and, while being colorless, have antioxidant activities.
  • anthocyanins will refer to naturally occurring and synthetic anthocyanins and proanthocyanins, as those terms are understood in the art.
  • Suitable substrates for growing mushrooms include grains having high levels of anthocyanins, as noted by the color of the grain.
  • anthocyanins such as purple corn and black corn have high levels of anthocyanins.
  • Purple barley and purple or black rice varieties are also known to contain high levels of anthocyanins.
  • Any variety of mushroom will benefit from the methods of the present invention, although due to the intended end use of the mushrooms the variety must be edible by humans. Suitable varieties include, but are not limited to, Coriolus versicolor, Ganoderma lucidum, Schizophyllum commune, Pleurotus ostreatus, Agaricus blazei, Lentinula edodes, Flammulina velutipes, Grifola frondonsus , and Codyceps sinensis.
  • the present invention provides a method of increasing the amount of selenium in medicinal mushroom biomass and mushroom mycelia comprising providing a substrate having selenium therein; and growing the mushrooms on the substrate.
  • Substrates suitable for growing mushrooms and having high levels of selenium include, but are not limited to, certain varieties of wheat such as triticum teranicum.
  • the present invention provides a method of increasing the amount of beta-glucan in medicinal mushroom biomass and mushroom mycelia comprising: providing a substrate having beta glucan therein; and growing the mushrooms on the substrate.
  • Beta-glucans are a family of polysaccharides known in the art for having antitumor properties, cholesterol lowering ability, and other beneficial properties.
  • Substrates having high levels of beta-glucans include, but are not limited to, certain varieties of barley such as waxy hulless barley.
  • the present invention provides a method of decreasing the growing time of mushrooms, by providing a substrate rich in anthocyanins. Suitable substrates are those as described above.
  • the mushrooms are grown on the anthocyanin-rich substrate, and the time to spawning and fruiting is decreased as compared to growing time on substrates not having anthocyanins. It has been found that the growing time can be decreased by 20-25%, using the methods of the present invention. This provides a significant advantage and benefit in the commercial production of mushrooms.
  • the present invention provides a method of increasing the potency of naturally-occurring medicinal compounds in mushrooms comprising: providing a substrate high in anthocyanins, and growing the mushrooms on the substrate.
  • the substrate is purple or black corn.
  • the term “increased potency” means increased levels or amounts of the naturally occurring medicinal compounds found in mushrooms. It has been found that growing mushrooms on substrates high in anthocyanins such as purple corn or other purple or black pigmented grain has the unexpected benefit of increasing the amounts of certain desirable compounds already present in medicinal mushrooms, including, but not limited to, triterpenes, ganoderic acid, cordycepin, adenosine, and hydroxyethyl-adenosine.
  • the substrate is prepared for each individual spawn bag.
  • the spawn bags are designed with a high efficiency particulate air (HEPA) filter and can be autoclave heat sterilized.
  • HEPA filter on the spawn bag allows the bag to breathe and protects the substrate from contamination.
  • Each spawn bag contains 5 pounds of prepared substrate consisting of a batch mix of about 3 pounds grain with about 2 pounds water.
  • the unsealed spawn bags are then autoclave steam sterilized up to a temperature of about 250° F. (approximately 15 psig) for a period of about 4-5 hours.
  • the cook time is the time that steam is supplied and shutdown to the autoclave. HEPA-filtered clean air is then applied for rapid cooldown of the autoclave.
  • the cooking time is determined by monitoring the inner core temperatures of the spawn substrate. Following autoclaving to sterilize the substrate, the spawn bags are then inoculated with spawn. The spawn bags are then heat sealed and the bags gently tumbled by machine or by hand to evenly distribute the spawn throughout the substrate. Thorough mixing may take a few seconds to a minute. Clean room conditions must be maintained during the process to prevent contamination of the substrate. The spawn bags are allowed to spawn run and mature for a period of about 1-2 months, after which time the mycelium-enriched spawn bags are harvested. The live (fresh) product can be sold by individual spawn bags without opening (or harvesting) the bags. If a dry product is desired, the spawn bags are opened and the live product contents are spread out on dryer trays.
  • the product is evenly distributed across the dryer tray with less than about 1′′ height.
  • the dryer trays are loaded into a convection air dryer.
  • the air temperature of the dryer may be adjusted from ambient room temperature to about 190° F. Usually the air temperatures are set to control around 150-170° F. and drying times are automatically set from 16-20 hours. The air temperatures can be set lower, requiring longer dry times. Freeze drying or vacuum drying may be used as alternative drying methods.
  • the final dried product is tested to have a less than or equal to about 5% by weight moisture content. Each spawn bag initially weighing 5 pounds (water and grain mix) is designed to produce slightly greater than 1 kg of dry product.
  • the dry product is powdered using a grinder with 40 mesh or finer screen.
  • the powder is then packaged into 3 kg plastic bags and the bags are sealed.
  • the bags are then autoclaved for final sterilization for up to approximately 15 hours, at temperatures between about 200° F. to about 270° F. (approximately 15 psig), depending on the amount of moisture removed during the drying step and other factors. Due to the low moisture content of the dry product, sterilization will take longer. Since the bags are sealed prior to sterilization, regulated air pressure is added to the autoclave during steam shutdown to avoid depressurization of the autoclave. This will prevent bags from being damaged due to the core temperatures in the bag unable to cool as fast as the pressure can decline based on temperature and pressure thermodynamic principles. Once the product is cooled, the product can be removed from the autoclave.
  • the present invention provides a method of increasing the amount of anthocyanins in dried mushroom biomass, comprising providing dried mushroom biomass, and subjecting the dried mushroom biomass to heat treatment.
  • the heat treatment is carried out for a period of up to about 15 hours, although shorter time intervals may increase the amount of anthocyanins to a lesser extent.
  • the heat treatment is carried out at temperatures of between about 200° F. to about 270° F., depending on the moisture content of the dried mushroom biomass and other factors, as will be understood by one skilled in the art. Autoclaving or any other suitable method of heat treatment can be used.
  • Specimens of Ganoderma lucidum were grown on purple corn by the methods known in the art and generally described above and shown in the flow chart in FIG. 1 .
  • Sample A Ganoderma lucidum (GL) grown on purple corn was tested prior to the final sterilization/heat treatment step for the presence of anthocyanins. The results are shown in Table 1.
  • TABLE 1 Ganoderma lucidum (grown on purple corn) GL-Sample A Analyte Result Unit Pelargonidin 0.0022 mg/g Peonidin 0.0018 mg/g Cyanidin 0.0001 mg/g Petunidin 0.0001 mg/g Malvidin 0.0000 mg/g Delphinidin 0.0001 mg/g
  • Sample B was prepared as above, including the final sterilization/heat treatment for about 10 hours at 250° F. Results are presented in Table 2.
  • Table 2 Ganoderma lucidum (grown on purple corn)
  • GL-Sample B Analyte Result Unit
  • Table 3 shows the results of live reishi antler (the fruiting body of Ganoderma lucidum ) grown on purple corn, with no further processing. As can be seen in these tables, anthocyanins were present in all three samples grown on purple corn. Mushrooms grown on other nonpigmented grains such as rice have undetectable levels of anthocyanins. Additionally, the heat treatment appears to increase the bioavailability of the anthocyanins in the mushrooms.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Environmental Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mushroom Cultivation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Methods of increasing the amount of one or more functional compounds in medicinal mushroom biomass and mushroom mycelia by growing the mushrooms on a substrate that is high in the functional compound or compounds of interest is provided. More specifically, a method of increasing the amount of anthocyanins in mushrooms is provided. Mushrooms are grown on a substrate rich in anthocyanins, such as purple corn or other suitable red, purple or black-pigmented substrate, and incorporate the anthocyanins during growth. Mushrooms grown by this method, as well as methods of improving the growth rate and potency of mushrooms, are also provided.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a divisional application of U.S. patent application Ser. No. 11/029,634, filed Jan. 5, 2005, which claims the benefit of U.S. Provisional Application No. 60/534,334, filed Jan. 5, 2004, which are incorporated herein by reference in their entirety.
    • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • This invention relates to substrates for use in growing mushrooms and methods of increasing the growth rate of mushrooms. Specifically, functional substrates having desirable compounds can be used to grow mushrooms, to increase the levels of these compounds in mushrooms and to improve the growth rate of the mushrooms. Additionally, functional substrates increase the potency of naturally occurring compounds already present in the mushrooms.
  • 2. Background Information
  • In the commercial method of producing mushrooms, a suitably prepared substrate such as corn, rice, millet or rye is impregnated with mushroom spores or previously collected mushroom mycelia. Under sterile lab conditions, the spores or mycelia are injected into the substrate, which has been prepared by soaking the grain in water and sterilizing it. Mycelia are the filamentous hyphae of a mushroom that collect water and nutrients to enable mushrooms to grow. The grains are incubated to promote full colonization of the mycelia, at which point the mycelia-laced grains are known as “spawn”. Spawning is usually done in a plurality of individual spawn bags. The substrate provides the nutrients necessary for mycelium growth. The mycelium-impregnated substrate is then allowed to develop under carefully controlled conditions of temperature and moisture, until the hyphae of the mycelium have permeated the substrate. This process usually takes anywhere from three to four weeks for the mycelium to fully colonize the spawn bag. The spawn bag is allowed to continue to grow until the mycelium enriched product can be harvested between four to eight weeks from the beginning of the process. Typically, mushroom growers purchase spawn or grow it themselves from agar plates, as will be known to one skilled in the art. In the commercial production of medicinal mushrooms, the spawn bag is the final product, which is then sold or the contents processed into dry powdered product.
  • Many mushrooms are known to have medicinal properties. For example, the maitake mushroom (Grifola frondosa) contains grifolan, an important beta-glucan polysaccharide and has been shown to activate macrophages, an important component of the immune system. Laboratory studies have shown that maitake extract can block the growth of cancer tumors and boost the immune function of mice with cancer.
  • It has also been found that shiitake mushrooms possess beneficial properties. A specific amino acid in shiitake helps speed up the processing of cholesterol in the liver. Shiitake also appears to be a formidable cancer fighter. A polysaccharide compound called lentinan has been isolated from shiitake, and in laboratory trials, lentinan appears to stimulate immune-system cells to clear the body of tumor cells. Shiitake appears to be effective against some of the more serious viruses, such as HIV and hepatitis B.
  • Reishi mushrooms have been used in China and Japan for years as a medicine for liver disorders, hypertension, and arthritis, and researchers have found that reishi has anti-allergic, anti-inflammatory, anti-viral, anti-bacterial, and antioxidant properties. In vitro experiments also indicate that reishi may help fight cancer tumors.
  • U.S. Pat. No. 6,747,065 describes methods of producing mushroom mycelia rich in trace minerals by culturing the mycelia in a broth to which supplements have been added.
  • It would be desirable to improve or enhance the medicinal properties of these and other mushrooms, and shorten the growing time for commercial purposes.
    • SUMMARY OF THE INVENTION
  • The present invention accomplishes the above by providing in a general aspect a method of increasing the amount of one or more functional compounds in mushrooms by growing the mushrooms on a substrate that is high in the functional compound or compounds of interest. The term “functional compound”, as used herein, means a compound known to one skilled in the art to have certain medicinal or other beneficial properties, such as antioxidant, anti-tumorigenic, antidiabetic, antiviral, and the like. It has been found that growing mushrooms on substrates that have high levels of the compounds of interest permits uptake of the compounds by the mushrooms during the growth cycle, and these levels are maintained during further processing of the mushrooms. Thus, in one aspect, the present invention provides a method of increasing the amount of anthocyanins in medicinal mushroom biomass and mushroom mycelia. The method comprises providing a substrate having one or more anthocyanins therein and growing mushrooms on the substrate. In additional aspects, the present invention provides methods of increasing certain other compounds in medicinal mushroom biomass and mushroom mycelia such as selenium or beta glucans, by providing a substrate high in these compounds and growing the mushrooms on the substrate.
  • In a further aspect, the present invention provides a method of decreasing the growing time of mushrooms, by providing a substrate rich in anthocyanins. The mushrooms are grown on the anthocyanin-rich substrate, and the time to fruiting is decreased as compared to growing time on substrates not having anthocyanins.
  • In yet a further aspect, the present invention provides a method of increasing the potency of naturally-occurring compounds found in medicinal mushroom biomass. The method comprises providing a substrate high in anthocyanins, and growing the mushrooms on the substrate.
  • In an additional aspect, the present invention provides a method of increasing the amount of anthocyanins in dried mushroom biomass, comprising providing dried mushroom biomass, and subjecting the dried mushroom biomass to heat treatment.
  • These and other aspects of the present invention will be come more readily apparent from the following figure, detailed description and appended claims.
    • BRIEF DESCRIPTION OF THE DRAWING
  • FIG. 1 is a flow chart illustrating the culturing of mushrooms according to a method of the present invention.
    • DETAILED DESCRIPTION OF THE INVENTION
  • Thus, in one aspect the present invention provides a method of increasing the amount of one or more functional compounds in medicinal mushroom biomass and mushroom mycelia by growing mushrooms on a substrate that is high in the functional compound or compounds of interest. Examples of “functional compounds” include compounds known to have antioxidant properties including, but not limited to, anthocyanins; compounds known to have antitumor properties including, but not limited to, beta glucans; selenium, ganoderic acid; triterpenes; and cordycepin.
  • As used herein, the term “mushroom biomass” refers to mushroom mycelia, fruiting bodies, spawn, or other life cycle stage of a mushroom, alone or in combination with each other or in combination with the substrate on which the mushroom is grown, including the functional substrates described herein. “Medicinal mushroom” refers to the varieties of mushrooms grown for their desired medicinal properties or compounds, as is known in the art.
  • Thus, in an additional aspect, the present invention provides a method of increasing the amount of anthocyanins in medicinal mushroom biomass and mushroom mycelia comprising providing a substrate having one or more anthocyanins therein; and growing mushrooms on the substrate.
  • Anthocyanins are well known in the art, and are naturally occurring compounds that are responsible for the red, purple, and blue colors of many fruits, vegetables, cereal grains, and flowers. For example, the colors of berry fruits, such as blueberries, bilberries, strawberries, raspberries, boysenberries, marionberries, cranberries, are due to many different anthocyanins. Over 300 structurally distinct anthocyanins have been identified in nature. Because anthocyanins are naturally occurring, they have attracted much interest for use as colorants for foods and beverages. Recently, the interest in anthocyanin pigments has intensified because of their possible health benefits as dietary antioxidants. For example, anthocyanin pigments of bilberries (Vaccinium myrtillus) have long been used for improving visual acuity and treating circulatory disorders. There is experimental evidence that certain anthocyanins and flavonoids have anti-inflammatory properties. In addition, there are reports that orally administered anthocyanins are beneficial for treating diabetes and ulcers and may have antiviral and antimicrobial activities. The chemical basis for these desirable properties of flavonoids is believed to be related to their antioxidant capacity. Thus, the antioxidant characteristics associated with berries and other fruits and vegetables have been attributed to their anthocyanin content.
  • Proanthocyanins are another class of flavonoid compounds that are found in fruits and vegetables and, while being colorless, have antioxidant activities. As used herein, the term “anthocyanins” will refer to naturally occurring and synthetic anthocyanins and proanthocyanins, as those terms are understood in the art.
  • Suitable substrates for growing mushrooms include grains having high levels of anthocyanins, as noted by the color of the grain. By way of example, certain varieties of corn such as purple corn and black corn have high levels of anthocyanins. Purple barley and purple or black rice varieties are also known to contain high levels of anthocyanins.
  • Any variety of mushroom will benefit from the methods of the present invention, although due to the intended end use of the mushrooms the variety must be edible by humans. Suitable varieties include, but are not limited to, Coriolus versicolor, Ganoderma lucidum, Schizophyllum commune, Pleurotus ostreatus, Agaricus blazei, Lentinula edodes, Flammulina velutipes, Grifola frondonsus, and Codyceps sinensis.
  • In an additional aspect, the present invention provides a method of increasing the amount of selenium in medicinal mushroom biomass and mushroom mycelia comprising providing a substrate having selenium therein; and growing the mushrooms on the substrate. Substrates suitable for growing mushrooms and having high levels of selenium include, but are not limited to, certain varieties of wheat such as triticum teranicum.
  • In yet a further aspect, the present invention provides a method of increasing the amount of beta-glucan in medicinal mushroom biomass and mushroom mycelia comprising: providing a substrate having beta glucan therein; and growing the mushrooms on the substrate. Beta-glucans are a family of polysaccharides known in the art for having antitumor properties, cholesterol lowering ability, and other beneficial properties. Substrates having high levels of beta-glucans include, but are not limited to, certain varieties of barley such as waxy hulless barley.
  • In a further aspect, the present invention provides a method of decreasing the growing time of mushrooms, by providing a substrate rich in anthocyanins. Suitable substrates are those as described above. The mushrooms are grown on the anthocyanin-rich substrate, and the time to spawning and fruiting is decreased as compared to growing time on substrates not having anthocyanins. It has been found that the growing time can be decreased by 20-25%, using the methods of the present invention. This provides a significant advantage and benefit in the commercial production of mushrooms.
  • In an additional aspect, the present invention provides a method of increasing the potency of naturally-occurring medicinal compounds in mushrooms comprising: providing a substrate high in anthocyanins, and growing the mushrooms on the substrate. Preferably, the substrate is purple or black corn.
  • As used herein, the term “increased potency” means increased levels or amounts of the naturally occurring medicinal compounds found in mushrooms. It has been found that growing mushrooms on substrates high in anthocyanins such as purple corn or other purple or black pigmented grain has the unexpected benefit of increasing the amounts of certain desirable compounds already present in medicinal mushrooms, including, but not limited to, triterpenes, ganoderic acid, cordycepin, adenosine, and hydroxyethyl-adenosine.
  • The substrate is prepared for each individual spawn bag. The spawn bags are designed with a high efficiency particulate air (HEPA) filter and can be autoclave heat sterilized. The HEPA filter on the spawn bag allows the bag to breathe and protects the substrate from contamination. Each spawn bag contains 5 pounds of prepared substrate consisting of a batch mix of about 3 pounds grain with about 2 pounds water. The unsealed spawn bags are then autoclave steam sterilized up to a temperature of about 250° F. (approximately 15 psig) for a period of about 4-5 hours. The cook time is the time that steam is supplied and shutdown to the autoclave. HEPA-filtered clean air is then applied for rapid cooldown of the autoclave. The cooking time is determined by monitoring the inner core temperatures of the spawn substrate. Following autoclaving to sterilize the substrate, the spawn bags are then inoculated with spawn. The spawn bags are then heat sealed and the bags gently tumbled by machine or by hand to evenly distribute the spawn throughout the substrate. Thorough mixing may take a few seconds to a minute. Clean room conditions must be maintained during the process to prevent contamination of the substrate. The spawn bags are allowed to spawn run and mature for a period of about 1-2 months, after which time the mycelium-enriched spawn bags are harvested. The live (fresh) product can be sold by individual spawn bags without opening (or harvesting) the bags. If a dry product is desired, the spawn bags are opened and the live product contents are spread out on dryer trays. The product is evenly distributed across the dryer tray with less than about 1″ height. The dryer trays are loaded into a convection air dryer. The air temperature of the dryer may be adjusted from ambient room temperature to about 190° F. Usually the air temperatures are set to control around 150-170° F. and drying times are automatically set from 16-20 hours. The air temperatures can be set lower, requiring longer dry times. Freeze drying or vacuum drying may be used as alternative drying methods. The final dried product is tested to have a less than or equal to about 5% by weight moisture content. Each spawn bag initially weighing 5 pounds (water and grain mix) is designed to produce slightly greater than 1 kg of dry product.
  • The dry product is powdered using a grinder with 40 mesh or finer screen. The powder is then packaged into 3 kg plastic bags and the bags are sealed. The bags are then autoclaved for final sterilization for up to approximately 15 hours, at temperatures between about 200° F. to about 270° F. (approximately 15 psig), depending on the amount of moisture removed during the drying step and other factors. Due to the low moisture content of the dry product, sterilization will take longer. Since the bags are sealed prior to sterilization, regulated air pressure is added to the autoclave during steam shutdown to avoid depressurization of the autoclave. This will prevent bags from being damaged due to the core temperatures in the bag unable to cool as fast as the pressure can decline based on temperature and pressure thermodynamic principles. Once the product is cooled, the product can be removed from the autoclave.
  • Surprisingly, it has been found that the final heat treatment step increases the amount of anthocyanins present in the dried mushroom biomass. Without wishing to be bound by any theory, it is thought that the heat treatment improves the bioavailability of the anthocyanins by releasing them from a bound form. Thus, in an additional aspect, the present invention provides a method of increasing the amount of anthocyanins in dried mushroom biomass, comprising providing dried mushroom biomass, and subjecting the dried mushroom biomass to heat treatment. Preferably, the heat treatment is carried out for a period of up to about 15 hours, although shorter time intervals may increase the amount of anthocyanins to a lesser extent. Also preferably, the heat treatment is carried out at temperatures of between about 200° F. to about 270° F., depending on the moisture content of the dried mushroom biomass and other factors, as will be understood by one skilled in the art. Autoclaving or any other suitable method of heat treatment can be used.
    • EXAMPLES
  • The following examples are intended to illustrate the invention and should not be construed as limiting the invention in any way.
  • Specimens of Ganoderma lucidum were grown on purple corn by the methods known in the art and generally described above and shown in the flow chart in FIG. 1. Sample A, Ganoderma lucidum (GL) grown on purple corn was tested prior to the final sterilization/heat treatment step for the presence of anthocyanins. The results are shown in Table 1.
    TABLE 1
    Ganoderma lucidum
    (grown on purple corn)
    GL-Sample A
    Analyte Result Unit
    Pelargonidin 0.0022 mg/g
    Peonidin 0.0018 mg/g
    Cyanidin 0.0001 mg/g
    Petunidin 0.0001 mg/g
    Malvidin 0.0000 mg/g
    Delphinidin 0.0001 mg/g
  • Sample B was prepared as above, including the final sterilization/heat treatment for about 10 hours at 250° F. Results are presented in Table 2.
    TABLE 2
    Ganoderma lucidum
    (grown on purple corn)
    GL-Sample B
    Analyte Result Unit
    Pelargonidin 0.0134 mg/g
    Peonidin 0.0579 mg/g
    Cyanidin 0.0121 mg/g
    Petunidin 0.0203 mg/g
    Malvidin 0.0065 mg/g
    Delphinidin 0.0078 mg/g
  • Table 3 shows the results of live reishi antler (the fruiting body of Ganoderma lucidum) grown on purple corn, with no further processing. As can be seen in these tables, anthocyanins were present in all three samples grown on purple corn. Mushrooms grown on other nonpigmented grains such as rice have undetectable levels of anthocyanins. Additionally, the heat treatment appears to increase the bioavailability of the anthocyanins in the mushrooms.
    TABLE 3
    Ganoderma lucidum
    (Reishi antler grown on purple corn)
    GL-Sample C
    Analyte Result Unit
    Pelargonidin 0.0086 mg/g
    Peonidin 0.0379 mg/g
    Cyanidin 0.0155 mg/g
    Petunidin 0.0024 mg/g
    Malvidin 0.0011 mg/g
    Delphinidin 0.0193 mg/g
  • All anthocyanin analysis was performed by methodology employed by Krawczyk, U., Petri, G., “Application of RP [reversed-phase]-HPLC and spectrophotometry in standardization of bilberry anthocyanoside extract” as published in Arch. Pharm. 1992, 325 (3), pp. 147-149 using Partisil 10 ODS (25 cm*4.6 mm) with gradient elution (0.5 ml min-1) with formic acid—acetonitrile (100:0 to 0:1 in 60 min then held to 90 min) and detection at 280 nm. Identification/quantification by external standards method; standard obtained from Sigma-Aldrich.
  • Whereas particular embodiments of this invention have been described above for purposes of illustration, it will be evident to those skilled in the art that numerous variations of the details of the present invention may be made without departing from the invention as defined in the appended claims.

Claims (9)

1. A method of increasing the amount of selenium in medicinal mushroom biomass and mushroom spawn comprising:
providing a substrate having selenium therein; and
growing mushrooms on the substrate.
2. The method of claim 1, wherein the substrate is a variety of wheat containing selenium.
3. The method of claim 2, wherein the wheat is triticum teranicum.
4. A method of increasing the amount of beta-glucan in medicinal mushroom biomass and mushroom spawn comprising:
providing a substrate having beta glucan therein; and
growing mushrooms on the substrate.
5. The method of claim 4, wherein the substrate is waxy hulless barley.
6. A method of increasing the amount of anthocyanins in dried mushroom biomass comprising:
providing dried mushroom biomass; and subjecting the dried mushroom biomass to heat treatment.
7. The method of claim 6, wherein the heat treatment is carried out for a period of up to about 15 hours.
8. The method of claim 6, wherein the heat treatment is carried out at a temperature of between about 200° F. to about 270° F.
9. The method of claim 6, wherein the heat treatment is carried out in an autoclave.
US11/653,773 2004-01-05 2007-01-16 Functional substrates for growth of culinary and medicinal mushrooms Abandoned US20070204507A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/653,773 US20070204507A1 (en) 2004-01-05 2007-01-16 Functional substrates for growth of culinary and medicinal mushrooms

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53433404P 2004-01-05 2004-01-05
US11/029,634 US7178285B2 (en) 2004-01-05 2005-01-05 Functional substrates for growth of culinary and medicinal mushrooms
US11/653,773 US20070204507A1 (en) 2004-01-05 2007-01-16 Functional substrates for growth of culinary and medicinal mushrooms

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/029,634 Division US7178285B2 (en) 2004-01-05 2005-01-05 Functional substrates for growth of culinary and medicinal mushrooms

Publications (1)

Publication Number Publication Date
US20070204507A1 true US20070204507A1 (en) 2007-09-06

Family

ID=34794269

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/029,634 Expired - Lifetime US7178285B2 (en) 2004-01-05 2005-01-05 Functional substrates for growth of culinary and medicinal mushrooms
US11/653,773 Abandoned US20070204507A1 (en) 2004-01-05 2007-01-16 Functional substrates for growth of culinary and medicinal mushrooms

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/029,634 Expired - Lifetime US7178285B2 (en) 2004-01-05 2005-01-05 Functional substrates for growth of culinary and medicinal mushrooms

Country Status (2)

Country Link
US (2) US7178285B2 (en)
WO (1) WO2005067581A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090269441A1 (en) * 2008-04-23 2009-10-29 The Penn State Research Foundation Methods and compositions for improving the nutritional content of mushrooms and fungi
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067581A2 (en) * 2004-01-05 2005-07-28 Functional Fungi, Llc Functional substrates for growth of culinary and medicinal mushrooms
US8642847B2 (en) * 2007-06-21 2014-02-04 Lee K. French Corn inbreds like FAR601 and hybrids thereof
CN102870668B (en) * 2012-10-11 2014-01-15 南京市蔬菜科学研究所 A kind of breeding method of black waxy corn inbred line
US20150305249A1 (en) * 2014-04-23 2015-10-29 Functional Fungi, Llc. Nutritionally and botanically enhanced mycelial mass
US11376291B2 (en) * 2015-12-04 2022-07-05 Byo Holdings, Llc Beneficial growth and constituents of mushrooms on substrate containing cannabis plant material
US10609873B2 (en) 2016-02-26 2020-04-07 Ancient Brands, Llc Enhanced mycelium growth medium and method
CO2018001097A1 (en) 2018-02-01 2019-08-09 Reishi Colombia S A S Functional food and process for obtaining
WO2023091717A1 (en) * 2021-11-19 2023-05-25 Blue Sun Mycology Group, LLC Methods of infusing foreign compounds into fungus organisms
CN119234619B (en) * 2024-12-02 2025-04-18 云南省农业科学院生物技术与种质资源研究所 A method for cultivating truffle mycorrhizal seedlings

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2338259A (en) * 1942-12-29 1944-01-04 Chester County Mushroom Lab Mushroom spawn and substrate therefor
US4617047A (en) * 1982-07-27 1986-10-14 Campbell Soup Company Mushroom supplement
US4764199A (en) * 1986-08-13 1988-08-16 Penford Products Method of preparing mushroom growing supplements from corn gluten meal
US4776872A (en) * 1985-09-30 1988-10-11 Monterey Mushrooms, Inc. Method and composition for enhancing mushroom growth
US4852297A (en) * 1987-06-23 1989-08-01 Moren Douglas L Method and article of manufacture for producing mushrooms from self contained vessels
US5291685A (en) * 1992-09-11 1994-03-08 The Penn State Research Foundation Intact seed-based delayed-release nutrient supplement for mushroom cultivation
US5514191A (en) * 1994-04-05 1996-05-07 Deerpoint Industries, Inc. Polymeric media amendment for growing mushrooms
US5979109A (en) * 1994-08-12 1999-11-09 Tommaso Sartor Method for growing mushrooms on protein-containing substrate
US6298598B1 (en) * 1999-08-17 2001-10-09 Sylvan America, Inc. Materials for mycoculture
US6569475B2 (en) * 2000-10-06 2003-05-27 Jae-Mahn Song Process for mycelial culture using grain
US6737065B2 (en) * 2000-10-06 2004-05-18 Jae-Mahn Song Method for producing mushroom mycelia and uses thereof
US6747065B1 (en) * 2000-09-01 2004-06-08 Chemical Products Corporation System and method for producing high purity colloidal silica and potassium hydroxide
US20040258711A1 (en) * 2003-04-09 2004-12-23 Siddharth Shastri Methods of producing edible fungi containing activated folates and nutritional supplements containing activated folates
US7178285B2 (en) * 2004-01-05 2007-02-20 Functional Fungi, Llc Functional substrates for growth of culinary and medicinal mushrooms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2656299B1 (en) * 1989-12-27 1992-05-07 Haraguy PROCESS FOR OBTAINING A NEW MUSHROOM CULTURE MEDIUM, DEVICE FOR IMPLEMENTING SAME AND MEDIUM THUS OBTAINED.
WO1998054948A1 (en) * 1997-06-06 1998-12-10 The Penn State Research Foundation Selenium enrichment of mushrooms
JP2002045034A (en) * 2000-08-07 2002-02-12 Oji Cornstarch Co Ltd Method for cultivating mushroom and mushroom growth- promoting composition

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2338259A (en) * 1942-12-29 1944-01-04 Chester County Mushroom Lab Mushroom spawn and substrate therefor
US4617047A (en) * 1982-07-27 1986-10-14 Campbell Soup Company Mushroom supplement
US4776872A (en) * 1985-09-30 1988-10-11 Monterey Mushrooms, Inc. Method and composition for enhancing mushroom growth
US4764199A (en) * 1986-08-13 1988-08-16 Penford Products Method of preparing mushroom growing supplements from corn gluten meal
US4852297A (en) * 1987-06-23 1989-08-01 Moren Douglas L Method and article of manufacture for producing mushrooms from self contained vessels
US5427592A (en) * 1992-09-11 1995-06-27 The Penn State Research Foundation Intact seed-based delayed-released nutrient supplement for mushroom cultivation
US5291685A (en) * 1992-09-11 1994-03-08 The Penn State Research Foundation Intact seed-based delayed-release nutrient supplement for mushroom cultivation
US5514191A (en) * 1994-04-05 1996-05-07 Deerpoint Industries, Inc. Polymeric media amendment for growing mushrooms
US5979109A (en) * 1994-08-12 1999-11-09 Tommaso Sartor Method for growing mushrooms on protein-containing substrate
US6298598B1 (en) * 1999-08-17 2001-10-09 Sylvan America, Inc. Materials for mycoculture
US6747065B1 (en) * 2000-09-01 2004-06-08 Chemical Products Corporation System and method for producing high purity colloidal silica and potassium hydroxide
US6569475B2 (en) * 2000-10-06 2003-05-27 Jae-Mahn Song Process for mycelial culture using grain
US6737065B2 (en) * 2000-10-06 2004-05-18 Jae-Mahn Song Method for producing mushroom mycelia and uses thereof
US20040258711A1 (en) * 2003-04-09 2004-12-23 Siddharth Shastri Methods of producing edible fungi containing activated folates and nutritional supplements containing activated folates
US7178285B2 (en) * 2004-01-05 2007-02-20 Functional Fungi, Llc Functional substrates for growth of culinary and medicinal mushrooms

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090269441A1 (en) * 2008-04-23 2009-10-29 The Penn State Research Foundation Methods and compositions for improving the nutritional content of mushrooms and fungi
US8337921B2 (en) 2008-04-23 2012-12-25 The Penn State Research Foundation Methods and compositions for improving the nutritional content of mushrooms and fungi
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee

Also Published As

Publication number Publication date
WO2005067581A2 (en) 2005-07-28
US7178285B2 (en) 2007-02-20
US20050178055A1 (en) 2005-08-18
WO2005067581A3 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
US20070204507A1 (en) Functional substrates for growth of culinary and medicinal mushrooms
US10881055B2 (en) Nutritionally and botanically enhanced mycelial mass
EP2474221B1 (en) Medium for cultivating truffles, truffle mycelium, and truffle fruiting body
CN1096832C (en) Process for preparing fungal flour, fungal bean powder nad fungal bean-milk powder as food or medicine
Daba et al. Production of mushroom (Pleurotus ostreatus) in Egypt as a source of nutritional and medicinal food
CN101103814B (en) Method for making mushroom nutrition protein powder
KR20100062085A (en) Method for manufacturing mushroom mycelial grain products
CN110326485B (en) Cultivation method and application of cultivated trametes heme
CN104969773B (en) The method for obtaining Cordyceps militaris fermentate or fructification using sweet potato dregs fermentation
US11376291B2 (en) Beneficial growth and constituents of mushrooms on substrate containing cannabis plant material
CN1379082A (en) Solid culture method of Antrodia camphorata, obtained solid culture and its products and uses
Luangharn et al. Proximate analysis and mineral content of Laetiporus sulphureus strain MFLUCC 12-0546 from northern Thailand
KR100668989B1 (en) Bean mushrooms and its production method
CN110915542A (en) Cordyceps militaris cultivation method with stable high-content cordycepic acid
JP3509736B2 (en) A method for preparing a fungus bed of Physcomitrella patens having physiological functions
KR20090003777A (en) A medium for growing oyster mushroom or enoki mushroom containing green tea components and a method of cultivating oyster mushroom or enoki mushroom using the same
KR101858222B1 (en) A medium for mass cultivation of a Sparassis crispa containing charcoal and a method for reduction of contamination rate using the same
JP2001112436A (en) Health food, feed and pet food containing basidiomycetes
CN110583363A (en) Process for cultivating lucid ganoderma by adopting substitute material
JOSE et al. Cultivation and nutritional studies on Ganoderma lucidum (Curt. Fr.) P. Karst, the leader of medicinal mushroom.
JP2016007146A (en) Cultivation method of mycelia and mycelium cultured thereby
KR102624448B1 (en) Method for producing functional fermented ginseng seed extract using grain mushroom mycelium seed culture
Goyal et al. High-performance liquid chromatography studies to estimate ergosterol content at different developmental stages of the lingzhi or reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes)
Njenga et al. Antibiotic Property of Edible and Non-Edible Wild Mushrooms from Menengai Crater in Kenya
KR20190066821A (en) A method of massively isolating and concentrating effective components from Grifola frodosa and a method of manufacturing powdered food for immune enhancement using the same

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION